FEATURED ARTICLES
How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients
Regeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.
-
Unicycive Therapeutics' Framework For Speedier Clinical Trials
Unicycive Therapeutics Vice President of R&D Guru Reddy, Ph.D., shares how his small team moved swiftly through a recent early phase trial.
-
Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder
Helus Pharma CMO Amir Inamdar discusses the strategic rationale behind its Phase 3 trial for major depressive disorder, including its adjunctive-treatment approach, patient population selection, and endpoint strategy.
-
RWE Increasingly Supports Rare Disease Research As RCTs Alone Fall Short
Chiesi's Rachele Berria, MD, Ph.D., discusses how RWE is reshaping rare disease drug development strategies, from leveraging registries and patient-reported outcomes to navigating evolving regulatory expectations.